数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Suleiman bin Mohamed 男 Independent Director 77 未披露 未持股 2026-08-06
CHEW Yoke Ling 女 Director 54 6.95万 688.27 2026-08-06
Intan Ilyani binti Ghazali 女 Independent Director 46 未披露 1.00 2026-08-06
CHUA Boon Ping 男 Independent Director 42 未披露 15.00 2026-08-06
THAM Seng Kong 男 Chief Executive Officer and Director 57 12.77万 7714.44 2026-08-06
Lee Hee Hang 男 Independent Director 62 未披露 2.00 2026-08-06

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
LOW Wei Sim 女 Chief Operating Officer 31 1.42万 82.11 2026-08-06
Manickam RAVICHANDRAN 男 Chief Scientific Officer 57 7.09万 2.00 2026-08-06
POH Chit Laa 女 Chief Vaccine Development Officer 75 5.15万 0.20 2026-08-06
THAM Seng Kong 男 Chief Executive Officer and Director 57 12.77万 7714.44 2026-08-06
CHEING Lye Ping 女 Chief Financial Officer 53 2.53万 未持股 2026-08-06

董事简历

中英对照 |  中文 |  英文
Suleiman bin Mohamed

苏莱曼·本·穆罕默德担任公司独立董事。丹斯里苏莱曼在新闻、政府和教育领域有着卓越的职业生涯。自2009年以来,他一直是Koperasi Khazanah Suria(KL)Berhad的创始人和董事长,这是一家专注于商业咨询和促进金融知识、教育以及为其成员进行规划的公司。2012年至2016年,担任UNITAR国际大学主席。丹斯里苏莱曼于1986年至2004年连续四届当选马来西亚国会议员。在任期间,他担任过几个重要职务,1999年至2004年担任卫生部副部长,1995年至1999年担任新闻部副部长,1987年至1995年担任首相署副部长。丹斯里苏莱曼拥有马来西亚Kebangsaan大学马来文研究哲学博士学位。他在印度尼西亚万隆的Negeri Padjadjaran大学获得新闻学博士学位和传播科学学士学位。丹斯里苏莱曼将不得不向董事会介绍他对马来西亚在医疗保健领域的政府政策和结构的深厚经验和知识。


Suleiman bin Mohamed serves as an independent director of the Company. Tan Sri Suleiman has had a distinguished career in journalism, government, and education. Since 2009, he has been the founder and Chairman of Koperasi Khazanah Suria (KL) Berhad, a company focused on business consulting and promoting financial literacy, education, and planning for its members. From 2012 to 2016, he served as the Chairman of UNITAR International University. Tan Sri Suleiman was elected as a Member of the Parliament of Malaysia for four consecutive terms from 1986 to 2004. During his tenure, he held several significant positions, Deputy Minister of Health from 1999 to 2004, Deputy Minister of Information from 1995 to 1999, and Deputy Minister of the Prime Minister's Department from 1987 to 1995. Tan Sri Suleiman holds a Doctorate in Philosophy in Malay Literature Studies from Universiti Kebangsaan Malaysia. He obtained a Doctorate in Journalism and a Bachelor's Degree in Communication Science from Universitas Negeri Padjadjaran, Bandung, Indonesia. Tan Sri Suleiman will has to the board his deep experience and knowledge of Malaysia's governmental policies and structure in the healthcare field.
苏莱曼·本·穆罕默德担任公司独立董事。丹斯里苏莱曼在新闻、政府和教育领域有着卓越的职业生涯。自2009年以来,他一直是Koperasi Khazanah Suria(KL)Berhad的创始人和董事长,这是一家专注于商业咨询和促进金融知识、教育以及为其成员进行规划的公司。2012年至2016年,担任UNITAR国际大学主席。丹斯里苏莱曼于1986年至2004年连续四届当选马来西亚国会议员。在任期间,他担任过几个重要职务,1999年至2004年担任卫生部副部长,1995年至1999年担任新闻部副部长,1987年至1995年担任首相署副部长。丹斯里苏莱曼拥有马来西亚Kebangsaan大学马来文研究哲学博士学位。他在印度尼西亚万隆的Negeri Padjadjaran大学获得新闻学博士学位和传播科学学士学位。丹斯里苏莱曼将不得不向董事会介绍他对马来西亚在医疗保健领域的政府政策和结构的深厚经验和知识。
Suleiman bin Mohamed serves as an independent director of the Company. Tan Sri Suleiman has had a distinguished career in journalism, government, and education. Since 2009, he has been the founder and Chairman of Koperasi Khazanah Suria (KL) Berhad, a company focused on business consulting and promoting financial literacy, education, and planning for its members. From 2012 to 2016, he served as the Chairman of UNITAR International University. Tan Sri Suleiman was elected as a Member of the Parliament of Malaysia for four consecutive terms from 1986 to 2004. During his tenure, he held several significant positions, Deputy Minister of Health from 1999 to 2004, Deputy Minister of Information from 1995 to 1999, and Deputy Minister of the Prime Minister's Department from 1987 to 1995. Tan Sri Suleiman holds a Doctorate in Philosophy in Malay Literature Studies from Universiti Kebangsaan Malaysia. He obtained a Doctorate in Journalism and a Bachelor's Degree in Communication Science from Universitas Negeri Padjadjaran, Bandung, Indonesia. Tan Sri Suleiman will has to the board his deep experience and knowledge of Malaysia's governmental policies and structure in the healthcare field.
CHEW Yoke Ling

CHEW YOKE Ling担任公司董事会董事。自2017年以来,她一直担任阿尔卑斯山的董事。凭借美容行业的背景,Chew女士利用她的专业知识推动了Alps Group Inc组织内的战略举措。作为营销总监,周女士负责监督阿尔卑斯公司产品和服务的销售和营销活动。她的职责延伸到阿尔卑斯山医疗旅游工作的规划和协调,为当地和国际客户提供服务。她于1992年获得斯坦福大学集团学院的市场营销文凭,并于1990年获得RIMA学院的秘书研究文凭。


CHEW Yoke Ling serves as a Director on the Company's board of director. She has served as a Director of Alps since 2017. With a background in the beauty industry, Ms. Chew has leveraged her expertise to drive strategic initiatives within Alps Group Inc's organization. In her role as a marketing director, Ms. Chew oversees sales and marketing activities for Alps' products and services. Her responsibilities extend to the planning and coordination of Alps medical tourism efforts, catering to both local and international clients. She obtained a Diploma in Marketing from Stamford Group of Colleges, in 1992, and a Diploma in Secretarial Studies from RIMA College, in 1990.
CHEW YOKE Ling担任公司董事会董事。自2017年以来,她一直担任阿尔卑斯山的董事。凭借美容行业的背景,Chew女士利用她的专业知识推动了Alps Group Inc组织内的战略举措。作为营销总监,周女士负责监督阿尔卑斯公司产品和服务的销售和营销活动。她的职责延伸到阿尔卑斯山医疗旅游工作的规划和协调,为当地和国际客户提供服务。她于1992年获得斯坦福大学集团学院的市场营销文凭,并于1990年获得RIMA学院的秘书研究文凭。
CHEW Yoke Ling serves as a Director on the Company's board of director. She has served as a Director of Alps since 2017. With a background in the beauty industry, Ms. Chew has leveraged her expertise to drive strategic initiatives within Alps Group Inc's organization. In her role as a marketing director, Ms. Chew oversees sales and marketing activities for Alps' products and services. Her responsibilities extend to the planning and coordination of Alps medical tourism efforts, catering to both local and international clients. She obtained a Diploma in Marketing from Stamford Group of Colleges, in 1992, and a Diploma in Secretarial Studies from RIMA College, in 1990.
Intan Ilyani binti Ghazali

Intan Ilyani Binti Ghazali担任公司独立董事。Intan女士在战略合作伙伴关系、品牌和利益相关者管理方面拥有丰富的经验。自2024年8月起,她担任水兴集团创投零售与电子商务副总裁。从2021年7月到2024年7月,Intan女士担任JLand Group战略合作伙伴与品牌负责人,负责管理与Petronas Gentari和Mitsui等公司的合作关系。此前,她曾在马来亚银行集团担任职务,包括2008年至2014年的董事长特别官员,以及2006年至2008年的行政、企业服务和法律。Intan女士还创立了护肤品牌Face and Co,并在2017年至2020年期间管理该品牌。Intan女士拥有2023年授予的马来西亚科技大学工商管理硕士学位,以及2000年授予的马来西亚MARA科技大学执行秘书文凭。


Intan Ilyani binti Ghazali serves as an independent director of the Company. Ms. Intan has extensive experience in strategic partnerships, branding, and stakeholder management. Since August 2024, she has served as Vice President of Retail & eCommerce at Shui Xing Group Ventures. From July 2021 to July 2024, Ms. Intan was the Head of Strategic Partnership & Branding at JLand Group, where she managed partnerships with companies including Petronas Gentari and Mitsui. Previously, she held roles at Maybank Group, including Special Officer to the Chairman from 2008 to 2014 and Executive, Corporate Services & Legal from 2006 to 2008. Ms. Intan also founded Face and Co, a skincare brand, and managed it from 2017 to 2020. Ms. Intan holds a Master of Business Administration from the University of Technology, Malaysia, awarded in 2023, and a Diploma in Executive Secretaryship from MARA University of Technology, Malaysia, awarded in 2000.
Intan Ilyani Binti Ghazali担任公司独立董事。Intan女士在战略合作伙伴关系、品牌和利益相关者管理方面拥有丰富的经验。自2024年8月起,她担任水兴集团创投零售与电子商务副总裁。从2021年7月到2024年7月,Intan女士担任JLand Group战略合作伙伴与品牌负责人,负责管理与Petronas Gentari和Mitsui等公司的合作关系。此前,她曾在马来亚银行集团担任职务,包括2008年至2014年的董事长特别官员,以及2006年至2008年的行政、企业服务和法律。Intan女士还创立了护肤品牌Face and Co,并在2017年至2020年期间管理该品牌。Intan女士拥有2023年授予的马来西亚科技大学工商管理硕士学位,以及2000年授予的马来西亚MARA科技大学执行秘书文凭。
Intan Ilyani binti Ghazali serves as an independent director of the Company. Ms. Intan has extensive experience in strategic partnerships, branding, and stakeholder management. Since August 2024, she has served as Vice President of Retail & eCommerce at Shui Xing Group Ventures. From July 2021 to July 2024, Ms. Intan was the Head of Strategic Partnership & Branding at JLand Group, where she managed partnerships with companies including Petronas Gentari and Mitsui. Previously, she held roles at Maybank Group, including Special Officer to the Chairman from 2008 to 2014 and Executive, Corporate Services & Legal from 2006 to 2008. Ms. Intan also founded Face and Co, a skincare brand, and managed it from 2017 to 2020. Ms. Intan holds a Master of Business Administration from the University of Technology, Malaysia, awarded in 2023, and a Diploma in Executive Secretaryship from MARA University of Technology, Malaysia, awarded in 2000.
CHUA Boon Ping

Chua Boon Ping担任公司独立董事。Chua先生在内部审计、风险管理、内部控制、可持续发展报告和公司治理方面拥有超过18年的经验。自2021年8月起,他在Kossan Rubber Industries Bhd担任风险管理和内部审计主管,负责监督公司的风险评估活动、内部审计职能、可持续发展相关事项和监管合规事项。2014年11月至2021年7月,他在AYS Ventures Berhad任职,在公司整体事务方面担任多个高级职务和职责,包括公司治理、战略规划、可持续发展报告、风险管理、内部审计、ISO和监管合规。Chua先生的职业生涯始于德勤企业风险服务私人有限公司的业务分析师,随后在马来西亚多家上市公司担任内部审计职务,涉及多个行业,包括贸易和制造、休闲和酒店、制粉、医疗保健、建筑和房地产开发。蔡先生于2005年获得英国赫特福德大学会计学学士学位(荣誉)。他是在马来西亚会计师协会(C.A.(M))注册的特许会计师,特许公认会计师协会(FCCA)会员,马来西亚内部审计师协会(CMIIA)专业会员。蔡先生对董事会来说,他在内部审计、内部控制、风险管理、可持续性和公司治理方面拥有专长。


CHUA Boon Ping serves as an independent director of the Company. Mr. Chua possesses over 18 years of experience in internal auditing, risk management, internal controls, sustainability reporting and corporate governance. Since August 2021, he has served as Head of Risk Management and Internal Audit at Kossan Rubber Industries Bhd, overseeing the company's risk assessment activities, internal audit functions, sustainability related matters and regulatory compliance matters. From November 2014 to July 2021, he was with AYS Ventures Berhad where he held various senior roles and responsibilities in overall corporate matters, including corporate governance, strategic planning, sustainability reporting, risk management, internal audits, ISO and regulatory compliances. Mr. Chua began his career as a Business Analyst with Deloitte Enterprise Risk Services Sdn Bhd and subsequently held internal audit roles in several public listed companies in Malaysia across diverse sectors including trading and manufacturing, leisure and hospitality, milling, healthcare, construction, and property development. Mr. Chua holds a Bachelor's Degree in Accounting (with Honours) from the University of Hertfordshire, United Kingdom, in 2005. He is a Chartered Accountant registered with the Malaysian Institute of Accountants (C.A.(M)), a Fellow of the Association of Chartered Certified Accountants (FCCA), and a Professional Member of The Institute of Internal Auditors Malaysia (CMIIA). Mr. Chua has to the board his expertise in internal auditing, internal controls, risk management, sustainability and corporate governance.
Chua Boon Ping担任公司独立董事。Chua先生在内部审计、风险管理、内部控制、可持续发展报告和公司治理方面拥有超过18年的经验。自2021年8月起,他在Kossan Rubber Industries Bhd担任风险管理和内部审计主管,负责监督公司的风险评估活动、内部审计职能、可持续发展相关事项和监管合规事项。2014年11月至2021年7月,他在AYS Ventures Berhad任职,在公司整体事务方面担任多个高级职务和职责,包括公司治理、战略规划、可持续发展报告、风险管理、内部审计、ISO和监管合规。Chua先生的职业生涯始于德勤企业风险服务私人有限公司的业务分析师,随后在马来西亚多家上市公司担任内部审计职务,涉及多个行业,包括贸易和制造、休闲和酒店、制粉、医疗保健、建筑和房地产开发。蔡先生于2005年获得英国赫特福德大学会计学学士学位(荣誉)。他是在马来西亚会计师协会(C.A.(M))注册的特许会计师,特许公认会计师协会(FCCA)会员,马来西亚内部审计师协会(CMIIA)专业会员。蔡先生对董事会来说,他在内部审计、内部控制、风险管理、可持续性和公司治理方面拥有专长。
CHUA Boon Ping serves as an independent director of the Company. Mr. Chua possesses over 18 years of experience in internal auditing, risk management, internal controls, sustainability reporting and corporate governance. Since August 2021, he has served as Head of Risk Management and Internal Audit at Kossan Rubber Industries Bhd, overseeing the company's risk assessment activities, internal audit functions, sustainability related matters and regulatory compliance matters. From November 2014 to July 2021, he was with AYS Ventures Berhad where he held various senior roles and responsibilities in overall corporate matters, including corporate governance, strategic planning, sustainability reporting, risk management, internal audits, ISO and regulatory compliances. Mr. Chua began his career as a Business Analyst with Deloitte Enterprise Risk Services Sdn Bhd and subsequently held internal audit roles in several public listed companies in Malaysia across diverse sectors including trading and manufacturing, leisure and hospitality, milling, healthcare, construction, and property development. Mr. Chua holds a Bachelor's Degree in Accounting (with Honours) from the University of Hertfordshire, United Kingdom, in 2005. He is a Chartered Accountant registered with the Malaysian Institute of Accountants (C.A.(M)), a Fellow of the Association of Chartered Certified Accountants (FCCA), and a Professional Member of The Institute of Internal Auditors Malaysia (CMIIA). Mr. Chua has to the board his expertise in internal auditing, internal controls, risk management, sustainability and corporate governance.
THAM Seng Kong

THAM Seng Kong担任公司董事会董事总经理。Tham博士自成立以来一直担任Alps的董事总经理、集团首席执行官和集团首席研究科学家。Tham博士是生命科学领域的资深人士,专注于细胞治疗领域。他是马来西亚干细胞研究与治疗学会和马来西亚细胞治疗协会的固定成员。自2006年以来,他一直参与正在进行的抗衰老细胞疗法的广泛研究。Tham博士还积极参与癌症研究。Tham博士于1994年获得厦门大学医学学士学位,2012年获得宾夕法尼亚州商业学院工商管理硕士学位。Tham博士于2017年获得广州中医药大学(GUCM)中西医结合临床医学(肿瘤学)博士学位。2025年1月1日,Tham博士被HELP大学任命为客座教授,承担教学和监督职责;2026年5月21日,他被Perdana大学任命为兼职教授,负责研究合作。


THAM Seng Kong serves as Managing Director on the Company's board of director. Dr. Tham has served as Alps' Managing Director, Group Chief Executive Officer and Group Chief Research Scientist since its inception. Dr. Tham is a veteran in the field of life sciences, with a focus in the field of Cellular Therapy. He is an established member of the Malaysian Society for Stem Cell Research & Therapy and the Malaysia Association for Cell Therapy. He has been involved in ongoing extensive research on anti aging cellular therapy since 2006. Dr. Tham also actively participates in cancer research. Dr. Tham obtained his Bachelor of Medicine from Xiamen University in 1994, and Masters of Business Administration from the Business Institute of Pennsylvania in 2012. Dr. Tham obtained his Ph.D. in Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) in 2017. On January 1, 2025, Dr. Tham was appointed as a Visiting Professor by HELP University, where he undertakes teaching and supervision responsibilities, and on May 21, 2026, he was appointed as an Adjunct Professor by Perdana University for research collaboration.
THAM Seng Kong担任公司董事会董事总经理。Tham博士自成立以来一直担任Alps的董事总经理、集团首席执行官和集团首席研究科学家。Tham博士是生命科学领域的资深人士,专注于细胞治疗领域。他是马来西亚干细胞研究与治疗学会和马来西亚细胞治疗协会的固定成员。自2006年以来,他一直参与正在进行的抗衰老细胞疗法的广泛研究。Tham博士还积极参与癌症研究。Tham博士于1994年获得厦门大学医学学士学位,2012年获得宾夕法尼亚州商业学院工商管理硕士学位。Tham博士于2017年获得广州中医药大学(GUCM)中西医结合临床医学(肿瘤学)博士学位。2025年1月1日,Tham博士被HELP大学任命为客座教授,承担教学和监督职责;2026年5月21日,他被Perdana大学任命为兼职教授,负责研究合作。
THAM Seng Kong serves as Managing Director on the Company's board of director. Dr. Tham has served as Alps' Managing Director, Group Chief Executive Officer and Group Chief Research Scientist since its inception. Dr. Tham is a veteran in the field of life sciences, with a focus in the field of Cellular Therapy. He is an established member of the Malaysian Society for Stem Cell Research & Therapy and the Malaysia Association for Cell Therapy. He has been involved in ongoing extensive research on anti aging cellular therapy since 2006. Dr. Tham also actively participates in cancer research. Dr. Tham obtained his Bachelor of Medicine from Xiamen University in 1994, and Masters of Business Administration from the Business Institute of Pennsylvania in 2012. Dr. Tham obtained his Ph.D. in Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) in 2017. On January 1, 2025, Dr. Tham was appointed as a Visiting Professor by HELP University, where he undertakes teaching and supervision responsibilities, and on May 21, 2026, he was appointed as an Adjunct Professor by Perdana University for research collaboration.
Lee Hee Hang

李熙航担任公司独立董事。李先生在金融服务领域拥有超过30年的经验。他于2002年7月至2025年6月担任安永会计师事务所合伙人,在此期间,他建立并领导了美洲财务会计咨询服务业务。此外,他还担任国际掉期和衍生品协会的顾问超过20年。Lee先生拥有克利夫兰州立大学会计和金融信息系统硕士学位和路易斯安那大学拉法叶分校工商管理学士学位。他是美国注册会计师协会会员,也是纽约州持牌的注册会计师。Lee先生在国外对资本市场、治理结构、SEC和国际财务报告框架有广泛的了解,对公司有广泛的业务和相关专业经验。


Lee Hee Hang serves as an independent director of the Company. Mr. Lee has over 30 years of experience in the financial services sector. He served as a Partner at Ernst & Young LLP from July 2002 to June 2025, during which period he established and led the Americas Financial Accounting Advisory Services practice. In addition, he served as an advisor to the International Swaps and Derivatives Association for more than 20 years. Mr. Lee holds a Master of Accountancy and Financial Information Systems from Cleveland State University and a Bachelor of Business Administration from the University of Louisiana at Lafayette. He is a member of the American Institute of Certified Public Accountants and a Certified Public Accountant licensed in the State of New York. Mr. Lee has abroad extensive knowledge of capital markets, governance structure, SEC and international financial reporting frameworks, and broad business and relevant professional experience to the Company.
李熙航担任公司独立董事。李先生在金融服务领域拥有超过30年的经验。他于2002年7月至2025年6月担任安永会计师事务所合伙人,在此期间,他建立并领导了美洲财务会计咨询服务业务。此外,他还担任国际掉期和衍生品协会的顾问超过20年。Lee先生拥有克利夫兰州立大学会计和金融信息系统硕士学位和路易斯安那大学拉法叶分校工商管理学士学位。他是美国注册会计师协会会员,也是纽约州持牌的注册会计师。Lee先生在国外对资本市场、治理结构、SEC和国际财务报告框架有广泛的了解,对公司有广泛的业务和相关专业经验。
Lee Hee Hang serves as an independent director of the Company. Mr. Lee has over 30 years of experience in the financial services sector. He served as a Partner at Ernst & Young LLP from July 2002 to June 2025, during which period he established and led the Americas Financial Accounting Advisory Services practice. In addition, he served as an advisor to the International Swaps and Derivatives Association for more than 20 years. Mr. Lee holds a Master of Accountancy and Financial Information Systems from Cleveland State University and a Bachelor of Business Administration from the University of Louisiana at Lafayette. He is a member of the American Institute of Certified Public Accountants and a Certified Public Accountant licensed in the State of New York. Mr. Lee has abroad extensive knowledge of capital markets, governance structure, SEC and international financial reporting frameworks, and broad business and relevant professional experience to the Company.

高管简历

中英对照 |  中文 |  英文
LOW Wei Sim

LOW Wei Sim担任公司首席运营官。自2024年4月1日起,Amanda女士被任命为Alps Group Inc的副首席运营官。在担任这一职务之前,她曾在同一家公司担任高级管理职务。自2018年12月1日起,Amanda女士担任AIiot Technologies Sdn.的董事。Bhd.,专业从事物联网(IoT)辅助信息系统开发及配套服务。此外,她还担任Alps Globemedic Sdn的执行董事。BHD.,一家致力于医疗保健业务发展的公司,自2018年11月。阿曼达于2018年在马来西亚新威大学获得商业研究理学学士(BSC)荣誉学位。


LOW Wei Sim serves as the Chief Operating Officer of the Company. Ms. Amanda has been appointed as Alps Group Inc's Deputy Chief Operating Officer from April 1, 2024. Prior to this role, she held a senior executive position within the same company. Since December 1, 2018, Ms. Amanda has served as a director at Aiiot Technologies Sdn. Bhd., which specializes in information system development and supporting services ancillary to the Internet of Things (IoT). Additionally, she also serves as the executive director in Alps Globemedic Sdn. Bhd., a company dedicated to healthcare business developments, since November 2018. Amanda obtained her Bachelor of Science (BSc) Hons. in Business Studies from Sunway University, Malaysia in 2018.
LOW Wei Sim担任公司首席运营官。自2024年4月1日起,Amanda女士被任命为Alps Group Inc的副首席运营官。在担任这一职务之前,她曾在同一家公司担任高级管理职务。自2018年12月1日起,Amanda女士担任AIiot Technologies Sdn.的董事。Bhd.,专业从事物联网(IoT)辅助信息系统开发及配套服务。此外,她还担任Alps Globemedic Sdn的执行董事。BHD.,一家致力于医疗保健业务发展的公司,自2018年11月。阿曼达于2018年在马来西亚新威大学获得商业研究理学学士(BSC)荣誉学位。
LOW Wei Sim serves as the Chief Operating Officer of the Company. Ms. Amanda has been appointed as Alps Group Inc's Deputy Chief Operating Officer from April 1, 2024. Prior to this role, she held a senior executive position within the same company. Since December 1, 2018, Ms. Amanda has served as a director at Aiiot Technologies Sdn. Bhd., which specializes in information system development and supporting services ancillary to the Internet of Things (IoT). Additionally, she also serves as the executive director in Alps Globemedic Sdn. Bhd., a company dedicated to healthcare business developments, since November 2018. Amanda obtained her Bachelor of Science (BSc) Hons. in Business Studies from Sunway University, Malaysia in 2018.
Manickam RAVICHANDRAN

Manickam Ravichandran担任公司首席科学官。Ravichandran教授自2022年12月1日起担任阿尔卑斯山首席科学官。他负责监督科研相关活动。他还担任AIMST大学应用科学学院院长,此前曾担任马来西亚AIMST大学副校长。Ravichandran教授于1988年获得印度马杜赖Kamaraj大学植物学理学学士学位。他于1991年在Vellore基督教医学院获得医学微生物学硕士学位,并于1977年在印度钦奈的安娜大学获得生物技术博士学位。Ravichandran教授还作为《热带生物医学杂志》的编辑委员会成员为学术界做出贡献,他自2020年7月7日以来一直担任该职位。Ravichandran教授的学术和研究卓越成就获得了44项国家和国际奖项的认可,其中包括来自德国纽伦堡IENA和日内瓦国际发明展等著名展览的荣誉。他还获得了马来西亚的Anugerah Inovasi Negara奖。作为马来西亚科学院‘Top Research Scientists Malaysia’的准成员和委员会成员。2025年12月12日,在马杜赖Kamaraj大学举行的一次会议上,他从尊敬的泰米尔纳德邦州长R. N. Ravi先生手中获得了理学博士(理学硕士)学位。


Manickam RAVICHANDRAN serves as the Company's Chief Scientific Officer. Professor Ravichandran has been Alps' Chief Scientific Officer since December 1, 2022. He is responsible for overseeing the scientific and research related activities. He also serves as the Dean of the Faculty of Applied Sciences at AIMST University, and previously served as the Vice Chancellor of AIMST University, Malaysia. Professor Ravichandran received his Bachelor of Science in Botany from Madurai Kamaraj University, India in 1988. He obtained his M.Sc. in Medical Microbiology from Christian Medical College, Vellore in 1991, and gained his Ph.D. in Biotechnology from Anna University, Chennai, India in 1977. Professor Ravichandran also contributes to the academic community as an Editorial Board Member of the Tropical Biomedicine Journal, a position he has held since July 7, 2020. Professor Ravichandran's academic and research excellence has been recognized with 44 national and international awards, including honors from prestigious exhibitions such as IENA in Nuremberg, Germany, and the International Exhibition of Inventions in Geneva. He has also been awarded the Anugerah Inovasi Negara in Malaysia. As an associate member and committee member of 'Top Research Scientists Malaysia' at the Academy of Sciences Malaysia. On December 12, 2025, he received The Doctor of Science (D.Sc.) degree from the honorable Governor of Tamil Nadu, Mr. R. N. Ravi, at a convocation held at Madurai Kamaraj University.
Manickam Ravichandran担任公司首席科学官。Ravichandran教授自2022年12月1日起担任阿尔卑斯山首席科学官。他负责监督科研相关活动。他还担任AIMST大学应用科学学院院长,此前曾担任马来西亚AIMST大学副校长。Ravichandran教授于1988年获得印度马杜赖Kamaraj大学植物学理学学士学位。他于1991年在Vellore基督教医学院获得医学微生物学硕士学位,并于1977年在印度钦奈的安娜大学获得生物技术博士学位。Ravichandran教授还作为《热带生物医学杂志》的编辑委员会成员为学术界做出贡献,他自2020年7月7日以来一直担任该职位。Ravichandran教授的学术和研究卓越成就获得了44项国家和国际奖项的认可,其中包括来自德国纽伦堡IENA和日内瓦国际发明展等著名展览的荣誉。他还获得了马来西亚的Anugerah Inovasi Negara奖。作为马来西亚科学院‘Top Research Scientists Malaysia’的准成员和委员会成员。2025年12月12日,在马杜赖Kamaraj大学举行的一次会议上,他从尊敬的泰米尔纳德邦州长R. N. Ravi先生手中获得了理学博士(理学硕士)学位。
Manickam RAVICHANDRAN serves as the Company's Chief Scientific Officer. Professor Ravichandran has been Alps' Chief Scientific Officer since December 1, 2022. He is responsible for overseeing the scientific and research related activities. He also serves as the Dean of the Faculty of Applied Sciences at AIMST University, and previously served as the Vice Chancellor of AIMST University, Malaysia. Professor Ravichandran received his Bachelor of Science in Botany from Madurai Kamaraj University, India in 1988. He obtained his M.Sc. in Medical Microbiology from Christian Medical College, Vellore in 1991, and gained his Ph.D. in Biotechnology from Anna University, Chennai, India in 1977. Professor Ravichandran also contributes to the academic community as an Editorial Board Member of the Tropical Biomedicine Journal, a position he has held since July 7, 2020. Professor Ravichandran's academic and research excellence has been recognized with 44 national and international awards, including honors from prestigious exhibitions such as IENA in Nuremberg, Germany, and the International Exhibition of Inventions in Geneva. He has also been awarded the Anugerah Inovasi Negara in Malaysia. As an associate member and committee member of 'Top Research Scientists Malaysia' at the Academy of Sciences Malaysia. On December 12, 2025, he received The Doctor of Science (D.Sc.) degree from the honorable Governor of Tamil Nadu, Mr. R. N. Ravi, at a convocation held at Madurai Kamaraj University.
POH Chit Laa

POH Chit Laa担任公司首席疫苗开发官。Poh教授自2024年起担任阿尔卑斯山首席疫苗开发官。Poh教授在高等教育领域有着享有盛誉的职业生涯,专注于医学微生物学、细菌学和生物技术。她曾于2011年至2024年担任新威大学病毒和疫苗研究中心特聘教授和负责人。Poh教授曾担任多个学术职务,包括2007年至2009年在斯威本科技大学(澳大利亚)担任环境生物技术教授,2005年至2006年在科廷科技大学(澳大利亚)担任生物医学科学教授。在她职业生涯的早期,Poh教授曾于1982年至2007年担任新加坡国立大学副教授。Poh教授于1975年以一级荣誉获得理学学士学位(BSC),并于1980年获得澳大利亚莫纳什大学医学微生物学和细菌学博士学位。此外,Poh教授作为日本生物技术学会出版的《生物科学与生物工程杂志》编辑委员会成员为学术界做出贡献,她自2023年以来一直担任该职务。


POH Chit Laa serves as the Company's Chief Vaccine Development Officer. Professor Poh is Alps' Chief Vaccine Development Officer since 2024. Professor Poh has a prestigious career in higher education, focusing on medical microbiology, bacteriology, and biotechnology. She has served as distinguished professor and Head of the Centre for Virus and Vaccine Research at Sunway University from 2011 to 2024. Professor Poh held numerous academic positions, including Professor of Environmental Biotechnology at Swinburne University of Technology (Australia) from 2007 to 2009, and Professor of Biomedical Science at Curtin University of Technology (Australia) from 2005 to 2006. Earlier in her career, Professor Poh was an Associate Professor at the National University of Singapore from 1982 to 2007. Professor Poh obtained a Bachelor of Science (BSc) with First Class Honors in 1975, and a Ph.D. in Medical Microbiology and Bacteriology from Monash University, Australia in 1980. Additionally, Professor Poh contributes to the academic community as a member of the Editorial Committee of the Journal of Bioscience and Bioengineering, published by the Society for Biotechnology in Japan, a role she has held since 2023.
POH Chit Laa担任公司首席疫苗开发官。Poh教授自2024年起担任阿尔卑斯山首席疫苗开发官。Poh教授在高等教育领域有着享有盛誉的职业生涯,专注于医学微生物学、细菌学和生物技术。她曾于2011年至2024年担任新威大学病毒和疫苗研究中心特聘教授和负责人。Poh教授曾担任多个学术职务,包括2007年至2009年在斯威本科技大学(澳大利亚)担任环境生物技术教授,2005年至2006年在科廷科技大学(澳大利亚)担任生物医学科学教授。在她职业生涯的早期,Poh教授曾于1982年至2007年担任新加坡国立大学副教授。Poh教授于1975年以一级荣誉获得理学学士学位(BSC),并于1980年获得澳大利亚莫纳什大学医学微生物学和细菌学博士学位。此外,Poh教授作为日本生物技术学会出版的《生物科学与生物工程杂志》编辑委员会成员为学术界做出贡献,她自2023年以来一直担任该职务。
POH Chit Laa serves as the Company's Chief Vaccine Development Officer. Professor Poh is Alps' Chief Vaccine Development Officer since 2024. Professor Poh has a prestigious career in higher education, focusing on medical microbiology, bacteriology, and biotechnology. She has served as distinguished professor and Head of the Centre for Virus and Vaccine Research at Sunway University from 2011 to 2024. Professor Poh held numerous academic positions, including Professor of Environmental Biotechnology at Swinburne University of Technology (Australia) from 2007 to 2009, and Professor of Biomedical Science at Curtin University of Technology (Australia) from 2005 to 2006. Earlier in her career, Professor Poh was an Associate Professor at the National University of Singapore from 1982 to 2007. Professor Poh obtained a Bachelor of Science (BSc) with First Class Honors in 1975, and a Ph.D. in Medical Microbiology and Bacteriology from Monash University, Australia in 1980. Additionally, Professor Poh contributes to the academic community as a member of the Editorial Committee of the Journal of Bioscience and Bioengineering, published by the Society for Biotechnology in Japan, a role she has held since 2023.
THAM Seng Kong

THAM Seng Kong担任公司董事会董事总经理。Tham博士自成立以来一直担任Alps的董事总经理、集团首席执行官和集团首席研究科学家。Tham博士是生命科学领域的资深人士,专注于细胞治疗领域。他是马来西亚干细胞研究与治疗学会和马来西亚细胞治疗协会的固定成员。自2006年以来,他一直参与正在进行的抗衰老细胞疗法的广泛研究。Tham博士还积极参与癌症研究。Tham博士于1994年获得厦门大学医学学士学位,2012年获得宾夕法尼亚州商业学院工商管理硕士学位。Tham博士于2017年获得广州中医药大学(GUCM)中西医结合临床医学(肿瘤学)博士学位。2025年1月1日,Tham博士被HELP大学任命为客座教授,承担教学和监督职责;2026年5月21日,他被Perdana大学任命为兼职教授,负责研究合作。


THAM Seng Kong serves as Managing Director on the Company's board of director. Dr. Tham has served as Alps' Managing Director, Group Chief Executive Officer and Group Chief Research Scientist since its inception. Dr. Tham is a veteran in the field of life sciences, with a focus in the field of Cellular Therapy. He is an established member of the Malaysian Society for Stem Cell Research & Therapy and the Malaysia Association for Cell Therapy. He has been involved in ongoing extensive research on anti aging cellular therapy since 2006. Dr. Tham also actively participates in cancer research. Dr. Tham obtained his Bachelor of Medicine from Xiamen University in 1994, and Masters of Business Administration from the Business Institute of Pennsylvania in 2012. Dr. Tham obtained his Ph.D. in Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) in 2017. On January 1, 2025, Dr. Tham was appointed as a Visiting Professor by HELP University, where he undertakes teaching and supervision responsibilities, and on May 21, 2026, he was appointed as an Adjunct Professor by Perdana University for research collaboration.
THAM Seng Kong担任公司董事会董事总经理。Tham博士自成立以来一直担任Alps的董事总经理、集团首席执行官和集团首席研究科学家。Tham博士是生命科学领域的资深人士,专注于细胞治疗领域。他是马来西亚干细胞研究与治疗学会和马来西亚细胞治疗协会的固定成员。自2006年以来,他一直参与正在进行的抗衰老细胞疗法的广泛研究。Tham博士还积极参与癌症研究。Tham博士于1994年获得厦门大学医学学士学位,2012年获得宾夕法尼亚州商业学院工商管理硕士学位。Tham博士于2017年获得广州中医药大学(GUCM)中西医结合临床医学(肿瘤学)博士学位。2025年1月1日,Tham博士被HELP大学任命为客座教授,承担教学和监督职责;2026年5月21日,他被Perdana大学任命为兼职教授,负责研究合作。
THAM Seng Kong serves as Managing Director on the Company's board of director. Dr. Tham has served as Alps' Managing Director, Group Chief Executive Officer and Group Chief Research Scientist since its inception. Dr. Tham is a veteran in the field of life sciences, with a focus in the field of Cellular Therapy. He is an established member of the Malaysian Society for Stem Cell Research & Therapy and the Malaysia Association for Cell Therapy. He has been involved in ongoing extensive research on anti aging cellular therapy since 2006. Dr. Tham also actively participates in cancer research. Dr. Tham obtained his Bachelor of Medicine from Xiamen University in 1994, and Masters of Business Administration from the Business Institute of Pennsylvania in 2012. Dr. Tham obtained his Ph.D. in Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) in 2017. On January 1, 2025, Dr. Tham was appointed as a Visiting Professor by HELP University, where he undertakes teaching and supervision responsibilities, and on May 21, 2026, he was appointed as an Adjunct Professor by Perdana University for research collaboration.
CHEING Lye Ping

车鹰黎萍担任公司首席财务官。Penny女士在金融和会计领域拥有超过30年的经验,包括在多个行业的上市公司和私营公司担任高级领导职务。在加入Alps Group Inc之前,2014年至2025年,Penny女士在一家物业开发公司担任首席财务官,主要从事市中心的综合混合用途开发项目。2009年至2013年,她担任Premier Asia Capital Sdn.首席执行官。Bhd.,在那里她领导了该公司的投资策略,并管理其投资和合资投资组合。2003年至2008年,她领导Equine Capital Berhad的企业事务部,Equine Capital Berhad是一家在马来西亚证券交易所主要市场上市的房地产开发公司。在这个职位上,她的主要职责包括财务报告、公司财务、公司治理、风险管理和投资者关系。在她职业生涯的早期,从1995年到2002年,她在Arthur Andersen & Co的审计部门工作,在该部门工作过一系列行业,包括制造业、航空和物流以及服务业。Penny女士拥有澳大利亚皇家理工大学商学学士(会计学)学位和澳大利亚迪肯大学工商管理硕士学位。她是在马来西亚会计师协会注册的特许会计师,也是澳洲会计师公会(FCPA)的会员。


CHEING Lye Ping serves as the Chief Financial Officer of the Company. Ms. Penny has over 30 years of experience in finance and accounting, including senior leadership roles in public listed and private companies across multiple industries. Prior to joining Alps Group Inc, from 2014 to 2025, Ms. Penny served as the Chief Financial Officer of a property development company primarily involved in an integrated mixed use development project in the city centre. From 2009 to 2013, she served as Chief Executive Officer of Premier Asia Capital Sdn. Bhd., where she led the company's investment strategies and managed its investment and joint venture portfolios. From 2003 to 2008, she headed the corporate affairs department of Equine Capital Berhad, a property development company listed on the Main Market of Bursa Malaysia. In this role, her key responsibilities included financial reporting, corporate finance, corporate governance, risk management, and investor relations. Earlier in her career, from 1995 to 2002, she was with the audit division of Arthur Andersen & Co, where she worked across a range of industries including manufacturing, aviation and logistics, and services. Ms. Penny holds a Bachelor of Business (Accountancy) from RMIT University, Australia, and a Master of Business Administration from Deakin University, Australia. She is a Chartered Accountant registered with the Malaysian Institute of Accountants and a Fellow of CPA Australia (FCPA).
车鹰黎萍担任公司首席财务官。Penny女士在金融和会计领域拥有超过30年的经验,包括在多个行业的上市公司和私营公司担任高级领导职务。在加入Alps Group Inc之前,2014年至2025年,Penny女士在一家物业开发公司担任首席财务官,主要从事市中心的综合混合用途开发项目。2009年至2013年,她担任Premier Asia Capital Sdn.首席执行官。Bhd.,在那里她领导了该公司的投资策略,并管理其投资和合资投资组合。2003年至2008年,她领导Equine Capital Berhad的企业事务部,Equine Capital Berhad是一家在马来西亚证券交易所主要市场上市的房地产开发公司。在这个职位上,她的主要职责包括财务报告、公司财务、公司治理、风险管理和投资者关系。在她职业生涯的早期,从1995年到2002年,她在Arthur Andersen & Co的审计部门工作,在该部门工作过一系列行业,包括制造业、航空和物流以及服务业。Penny女士拥有澳大利亚皇家理工大学商学学士(会计学)学位和澳大利亚迪肯大学工商管理硕士学位。她是在马来西亚会计师协会注册的特许会计师,也是澳洲会计师公会(FCPA)的会员。
CHEING Lye Ping serves as the Chief Financial Officer of the Company. Ms. Penny has over 30 years of experience in finance and accounting, including senior leadership roles in public listed and private companies across multiple industries. Prior to joining Alps Group Inc, from 2014 to 2025, Ms. Penny served as the Chief Financial Officer of a property development company primarily involved in an integrated mixed use development project in the city centre. From 2009 to 2013, she served as Chief Executive Officer of Premier Asia Capital Sdn. Bhd., where she led the company's investment strategies and managed its investment and joint venture portfolios. From 2003 to 2008, she headed the corporate affairs department of Equine Capital Berhad, a property development company listed on the Main Market of Bursa Malaysia. In this role, her key responsibilities included financial reporting, corporate finance, corporate governance, risk management, and investor relations. Earlier in her career, from 1995 to 2002, she was with the audit division of Arthur Andersen & Co, where she worked across a range of industries including manufacturing, aviation and logistics, and services. Ms. Penny holds a Bachelor of Business (Accountancy) from RMIT University, Australia, and a Master of Business Administration from Deakin University, Australia. She is a Chartered Accountant registered with the Malaysian Institute of Accountants and a Fellow of CPA Australia (FCPA).